UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016668
Receipt number R000019344
Scientific Title Associations between Major Adverse Cardiac Events and Various Parameters in Patients with Cardiovascular Diseases with or without Cardiac Rehabilitation
Date of disclosure of the study information 2015/02/28
Last modified on 2015/02/28 23:16:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Associations between Major Adverse Cardiac Events and Various Parameters in Patients with Cardiovascular Diseases with or without Cardiac Rehabilitation

Acronym

Cardiac rehabilitation and MACE

Scientific Title

Associations between Major Adverse Cardiac Events and Various Parameters in Patients with Cardiovascular Diseases with or without Cardiac Rehabilitation

Scientific Title:Acronym

Cardiac rehabilitation and MACE

Region

Japan


Condition

Condition

Cardiovascular disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We evaluate the associations between with or without cardiac rehabilitation and major adverse cardiac events (MACE) and various parameters in patients with cardiovascular disease during follow-up period (36 months).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

MACE (admission, onset of cardiovascular event, all-cause of death) in patients with and without cardiac rehabilitation during follow-up period (for 36 months)

Key secondary outcomes

Associations between with or without cardiac rehabilitation and various parameters [conventional cardiovascular risk factors (age, gender, obesity, smoking, hypertension, dyslipidemia, diabetes), blood pressure profile, lipid profile, various biomarkers, various hemodynamic and atherosclerotic parameters] during follow-up period (pre, 3, 6, 12, 24 and months).


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients with cardiovascular disease
2.Age is 20 years old or more
3.Patients who gave their informed consent to participate for the present study

Key exclusion criteria

1.Severe liver dysfunction
2.Severe renal dysfunction
3.Ineligible patients according to the judgment by physician

Target sample size

400


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Keijiro Saku

Organization

Fukuoka University School of Medicine

Division name

Department of Cardiology

Zip code


Address

7-45-1 Nanakuma, Jonan-Ku, Fukuoka.

TEL

81-92-801-1011

Email

saku-k@fukuoka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shin-ichiro Miura

Organization

Fukuoka University School of Medicine

Division name

Department of Cardiology

Zip code


Address

7-45-1 Nanakuma, Jonan-Ku, Fukuoka.

TEL

81-92-801-1011

Homepage URL


Email

miuras@cis.fukuoka-u.ac.jp


Sponsor or person

Institute

Department of Cardiology, Fukuoka University School of Medicine.

Institute

Department

Personal name



Funding Source

Organization

Department of Cardiology, Fukuoka University School of Medicine.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

福岡大学病院(福岡県)


Other administrative information

Date of disclosure of the study information

2015 Year 02 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2014 Year 04 Month 02 Day

Date of IRB


Anticipated trial start date

2014 Year 05 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

One hundred patients were enrolled.


Management information

Registered date

2015 Year 02 Month 28 Day

Last modified on

2015 Year 02 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019344


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name